PTC Therapeutics, Inc.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US69366J2006
USD
71.97
-0.67 (-0.92%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Net Sales
360.52
272.55
164.68
211.01
178.88
1,176.10
213.17
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
360.52
272.55
164.68
211.01
178.88
1,176.10
213.17
Raw Material Cost
31.76
39.61
16.30
23.32
15.48
16.66
19.59
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
48.48
49.03
55.19
32.59
30.36
34.09
41.06
Selling and Distribution Expenses
80.63
86.98
100.47
84.85
91.16
82.86
84.68
Other Expenses
5.07
5.18
7.79
6.76
8.26
7.49
8.37
Total Expenditure (Excl Depreciation)
211.54
227.47
249.90
208.32
219.63
208.49
229.04
Operating Profit (PBDIT) excl Other Income
149
45.099999999999994
-85.19999999999999
2.7
-40.8
967.6
-15.9
Other Income
-2.95
1.61
-12.55
6.50
-5.74
-6.30
108.75
Operating Profit (PBDIT)
161.90
62.91
-81.27
21.10
-33.01
970.42
99.64
Interest
48.48
49.03
55.19
32.59
30.36
34.09
41.06
Exceptional Items
0.00
-0.93
10.28
-0.47
-0.10
0.72
-146.52
Gross Profit (PBDT)
328.76
232.94
148.38
187.69
163.39
1,159.44
193.58
Depreciation
15.87
15.41
12.90
11.11
7.58
7.22
6.76
Profit Before Tax
97.55
-2.46
-139.08
-23.07
-71.05
929.83
-94.70
Tax
14.05
0.35
-4.12
-38.97
-6.20
63.27
-28.81
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
83.50
-2.81
-134.97
15.90
-64.85
866.56
-65.89
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
83.50
-2.81
-134.97
15.90
-64.85
866.56
-65.89
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
83.50
-2.81
-134.97
15.90
-64.85
866.56
-65.89
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
-165.36
-180.47
-205.31
-155.76
-206.55
-185.76
-1,098.07
Earnings per share (EPS)
0.92
-0.03
-1.67
0.2
-0.83
10.04
-0.85
Diluted Earnings per share
0.92
-0.03
-1.67
0.2
-0.83
10.04
-0.85
Operating Profit Margin (Excl OI)
41.32%
16.84%
-49.57%
1.65%
-19.49%
82.43%
-7.45%
Gross Profit Margin
31.46%
4.75%
-76.62%
-5.67%
-35.48%
79.67%
-41.25%
PAT Margin
23.16%
-1.03%
-81.96%
7.53%
-36.25%
73.68%
-30.91%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Jun 2026 is 32.25% vs 65.51% in Mar 2026

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Jun 2026 is 3,082.14% vs 97.93% in Mar 2026

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Jun 2026 is 169.00% vs 189.23% in Mar 2026

stock-summary

Interest

QoQ Growth in quarter ended Jun 2026 is -1.02% vs -11.23% in Mar 2026

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026

Compare Quarterly Results Of PTC Therapeutics, Inc. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Net Sales
360.52
0.00
360.52
Other Operating Income
0.00
0.00
0.00
Total Operating income
360.52
0.00
360.52
Raw Material Cost
31.76
0.62
31.14
5,022.58%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
44.35
-44.35
-100.00%
Power Cost
0
0
0.00
Manufacturing Expenses
48.48
0.00
48.48
Selling and Distribution Expenses
80.63
23.46
57.17
243.69%
Other Expenses
5.07
5.65
-0.58
-10.27%
Total Expenditure (Excl Depreciation)
211.54
124.90
86.64
69.37%
Operating Profit (PBDIT) excl Other Income
148.98
-124.90
273.88
219.28%
Other Income
-2.95
2.62
-5.57
-212.60%
Operating Profit (PBDIT)
161.90
-121.66
283.56
233.08%
Interest
48.48
0.00
48.48
Exceptional Items
0.00
-14.64
14.64
100.00%
Gross Profit (PBDT)
328.76
-0.62
329.38
53,125.81%
Depreciation
15.87
0.62
15.25
2,459.68%
Profit Before Tax
97.55
-136.92
234.47
171.25%
Tax
14.05
0.39
13.66
3,502.56%
Provisions and contingencies
0
0
0.00
Profit After Tax
83.50
-137.31
220.81
160.81%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
83.50
-137.31
220.81
160.81%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
83.50
-137.31
220.81
160.81%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
-165.36
12.22
-177.58
-1,453.19%
Earnings per share (EPS)
0.92
-0.91
1.83
201.10%
Diluted Earnings per share
0.92
-0.91
1.83
201.10%
Operating Profit Margin (Excl OI)
41.32%
0.00%
0.00
41.32%
Gross Profit Margin
31.46%
0.00%
0.00
31.46%
PAT Margin
23.16%
0.00%
0.00
23.16%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 36.05 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is 32.25% vs 65.51% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 101.51% vs -4.18% in Jun 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 8.35 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is 3,082.14% vs 97.93% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 228.86% vs 34.68% in Jun 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 16.49 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is 169.00% vs 189.23% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 704.03% vs -3.80% in Jun 2025

Quarterly - Interest
Interest 4.85 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is -1.02% vs -11.23% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 59.54% vs -30.11% in Jun 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 41.32%
in Jun 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 has improved from Jun 2025